Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K2PH
|
||||
Former ID |
DNC000601
|
||||
Drug Name |
Elvucitabine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Discontinued in Phase 2 | [546317] | ||
Structure |
Download2D MOL |
||||
Formula |
C9H10FN3O3
|
||||
Canonical SMILES |
C1=CC(OC1CO)N2C=C(C(=NC2=O)N)F
|
||||
InChI |
1S/C9H10FN3O3/c10-6-3-13(9(15)12-8(6)11)7-2-1-5(4-14)16-7/h1-3,5,7,14H,4H2,(H2,11,12,15)/t5-,7+/m1/s1
|
||||
InChIKey |
HSBKFSPNDWWPSL-VDTYLAMSSA-N
|
||||
CAS Number |
CAS 181785-84-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | HIV reverse transcriptase | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.